As of May 21
| -0.0213 / -2.54%|
The 1 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 0.96, with a high estimate of 0.96 and a low estimate of 0.96. The median estimate represents a +17.26% increase from the last price of 0.82.
The current consensus among 1 polled investment analysts is to Hold stock in Cyclacel Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.